Yamaguchi K - Search Results

1

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.

Akiyama Y, Oshita C, Kume A, Iizuka A, Miyata H, Komiyama M, Ashizawa T, Yagoto M, Abe Y, Mitsuya K, Watanabe R, Sugino T, Yamaguchi K, Nakasu Y. Akiyama Y, et al. Among authors: yamaguchi k. BMC Cancer. 2012 Dec 27;12:623. doi: 10.1186/1471-2407-12-623. BMC Cancer. 2012. PMID: 23270484 Free PMC article. Clinical Trial.

2

Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.

Akiyama Y, Maruyama K, Mochizuki T, Sasaki K, Takaue Y, Yamaguchi K. Akiyama Y, et al. Among authors: yamaguchi k. Immunol Lett. 2002 Aug 1;83(1):21-30. doi: 10.1016/s0165-2478(02)00073-1. Immunol Lett. 2002. PMID: 12057851

3

Antitumor effects induced by dendritic cell-based immunotherapy against established pancreatic cancer in hamsters.

Akiyama Y, Maruyama K, Nara N, Hojo T, Cheng JY, Mori T, Wiltrout RH, Yamaguchi K. Akiyama Y, et al. Among authors: yamaguchi k. Cancer Lett. 2002 Oct 8;184(1):37-47. doi: 10.1016/s0304-3835(02)00189-1. Cancer Lett. 2002. PMID: 12104046

4

Retroviral-mediated IL-12 gene transduction into human CD34+ cell-derived dendritic cells.

Akiyama Y, Maruyama K, Watanabe M, Yamaguchi K. Akiyama Y, et al. Among authors: yamaguchi k. Int J Oncol. 2002 Sep;21(3):509-14. Int J Oncol. 2002. PMID: 12168093

5

Hamster DEC-205, its primary structure, tissue and cellular distribution.

Maruyama K, Akiyama Y, Cheng J, Nara-Ashizawa N, Hojo T, Sasaki K, Yamaguchi K. Maruyama K, et al. Among authors: yamaguchi k. Cancer Lett. 2002 Jul 26;181(2):223-32. doi: 10.1016/s0304-3835(02)00067-8. Cancer Lett. 2002. PMID: 12175539

6

Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines.

Sasaki K, Sato K, Akiyama Y, Yanagihara K, Oka M, Yamaguchi K. Sasaki K, et al. Among authors: yamaguchi k. Cancer Res. 2002 Sep 1;62(17):4894-8. Cancer Res. 2002. PMID: 12208737

7

Cytotoxic T cell induction against human malignant melanoma cells using HLA-A24-restricted melanoma peptide cocktail.

Akiyama Y, Maruyama K, Nara N, Mochizuki T, Yamamoto A, Yamazaki N, Kawashima I, Nukaya I, Takesako K, Yamaguchi K. Akiyama Y, et al. Among authors: yamaguchi k. Anticancer Res. 2004 Mar-Apr;24(2B):571-7. Anticancer Res. 2004. PMID: 15160996 Free article.

8

Analysis of HLA-A24-restricted CMVpp65 peptide-specific CTL with HLA-A*2402-CMVpp65 tetramer.

Akiyama Y, Kuzushima K, Tsurumi T, Yamaguchi K. Akiyama Y, et al. Among authors: yamaguchi k. Immunol Lett. 2004 Sep;95(2):199-205. doi: 10.1016/j.imlet.2004.07.010. Immunol Lett. 2004. PMID: 15388261

9

Antitumor effect induced by dendritic cell (DC)-based immunotherapy against peritoneal dissemination of the hamster pancreatic cancer.

Takigawa Y, Akiyama Y, Maruyama K, Sugiyama K, Uchida E, Kosuge T, Ueda M, Kitajima M, Yamaguchi K. Takigawa Y, et al. Among authors: yamaguchi k. Cancer Lett. 2004 Nov 25;215(2):179-86. doi: 10.1016/j.canlet.2004.07.007. Cancer Lett. 2004. PMID: 15488636

10

Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells.

Akiyama Y, Tanosaki R, Inoue N, Shimada M, Hotate Y, Yamamoto A, Yamazaki N, Kawashima I, Nukaya I, Takesako K, Maruyama K, Takaue Y, Yamaguchi K. Akiyama Y, et al. Among authors: yamaguchi k. J Transl Med. 2005 Jan 28;3(1):4. doi: 10.1186/1479-5876-3-4. J Transl Med. 2005. PMID: 15676080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,741 results

Search Page

Filters